Pharmacometabolomic profiles in type 2 diabetic subjects treated with liraglutide or glimepiride
Sign Up to like & getrecommendations! Published in 2021 at "Cardiovascular Diabetology"
DOI: 10.1186/s12933-021-01431-2
Abstract: Background Treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) leads to multiple metabolic changes, reduction in glucose levels and body weight are well established. In people with type 2 diabetes, GLP-1 RAs reduce the risk… read more here.
Keywords: liraglutide glimepiride; treatment; disease; metabolism ... See more keywords